Clinical Trial: Analysis of First-line Treatment and Post-progression Treatment Patterns with PD-1/L1 Inhibitors in Advanced NSCLC and Their Clinical Outcomes: A Real-world Prospective Study (China)

Posted On: 2026-09-23

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of First-line Treatment and Post-progression Treatment Patterns with PD-1/L1 Inhibitors in Advanced NSCLC and Their Clinical Outcomes: A Real-world Prospective Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133166

Registration Time: 2026/09/22

Type: Observational study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344135

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Analysis of First-line Treatment and Post-progression Treatment Patterns with PD-1/L1 Inhibitors in Advanced NSCLC and Their Clinical Outcomes: A Real-world Prospective Study (China)